Results 21 to 30 of about 25,487 (238)
Serum osteoprotegerin levels in school-aged children with asthma [PDF]
, 2020 Background: Various inflammatory biomarkers have been used in asthma cases for evaluating inflammation, however it has been determined that the majority of these biomarkers are insufficient for putting forth the course and severity of the disease ...
Nacaroğlu, Hikmet Tekin +4 more
core +1 more source
Medicina, 2022 Background and objective: There is limited information as to the association of several key bone markers with bone mineral density (BMD) in understudied ethnic groups. This study investigated the relationship between circulating levels of osteoprotegerin
Osama E. Amer +8 more
doaj +1 more source
Osteoporosis associated with neutralizing autoantibodies against osteoprotegerin [PDF]
, 2009 Autoantibodies against osteoprotegerin, which block the inhibitory effect of osteoprotegerin on signaling by the receptor activator of nuclear factor (NF)-kappaB (RANK), were identified in a man with celiac disease who presented with severe osteoporosis ...
Ralston, Stuart H. +5 more
core +1 more source
Diagnostics, 2021 Arterial stiffness (AS) is a complex vascular phenomenon with consequences for central hemodynamics and left-ventricular performance. Circulating biomarkers have been associated with AS; however, their value in heart failure is poorly characterized.
Lajos Fehérvári +7 more
doaj +1 more source
OSTEOPROTEGERIN AND BONE DENSITY [PDF]
Biomedical Papers, 2001 Aim of study was determine if a correlation exists between bone mass density and concentration of osteoprotegerin. We examined the group of 199 patients of mean age of 63 years. Of the group under study, 31 patients had normal bone density (T score > -1 and < 1) and 168 probands had osteopenia or osteoporosis (T < -1).
D, Stejskal +4 more
openaire +2 more sources
Bone & Joint Research, 2023 Aims: Osteoporosis is characterized by decreased trabecular bone volume, and microarchitectural deterioration in the medullary cavity. Interleukin-19 (IL-19), a member of the IL-10 family, is an anti-inflammatory cytokine produced primarily by ...
Zhicheng Dai +7 more
doaj +1 more source
OSTEOPROTEGERIN, RANK, RANKL [PDF]
Biomedical Papers, 2001 Osteoprotegerin, RANK (Receptor Activator of Nuclear factor kappa B) and RANKL (Receptor Activator of Nuclear faktor kappa B ligand) became the aim of intensive research. RANK is considered as a hematopoietic surface receptor controlling osteoclastogenesis and calcium metabolism.
D, Stejskal +5 more
openaire +2 more sources
The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption [PDF]
Journal of Bone and Mineral Research, 2000 Abstract Although multiple hormones and cytokines regulate various aspects of osteoclast formation, the final two effectors are osteoprotegerin ligand (OPG-L)/osteoclast differentiation factor (ODF), a recently cloned member of the tumor necrosis factor superfamily, and macrophage colony–stimulating factor.
L C, Hofbauer +5 more
openaire +2 more sources
Life, 2023 Cardiovascular calcifications (CVC) are frequently observed in chronic kidney disease (CKD) patients and contribute to their cardiovascular mortality. The aim of the present study was to investigate the impact of osteoprotegerin (OPG)/Receptor Activator ...
Michalis Spartalis +9 more
doaj +1 more source
Could osteoprotegerin serve as a marker of metabolic syndrome?
Current Issues in Pharmacy and Medical Sciences, 2013 There has been a dramatic increase in the worldwide prevalence of obesity, which is associated with the development of several chronic diseases such as metabolic syndrome, type 2 diabetes and cardiovascular diseases.
Anna Maria Dąbrowska +6 more
doaj +1 more source